According to the Wise Finance APP, with the accelerated advancement of the "Hundred Models Battle", the application of large AI models in vertical fields is gradually deepening. On September 28, on the eve of the 25th "World Heart Day", at the "First Peking-Beijing Cardiovascular Innovation and Application Conference" held in Peking, a AI large model medical specialty application product named "Cardiovascular Guidelines Interpretation Intelligence" was officially launched. This intelligence uses advanced large model technology, aiming to serve as an "assistant to cardiologists", helping doctors to quickly and accurately interpret and apply the latest guidelines, improve the accuracy and efficiency of diagnosis and treatment decisions, and promote the standardization and normalization of cardiovascular disease diagnosis and treatment.

Launch Ceremony of Cardiovascular Guidelines Interpretation Intelligence

Main Functions of the Intelligence

Intelligent Q&A and Knowledge Acquisition: Deep learning of clinical cardiology guidelines, supporting voice and text input for questions, accurately understanding issues, and providing precise answers based on guidelines.

Interactive Learning and Efficiency Improvement: Multi-modal interaction, quickly locating relevant guideline content to save lookup time; intelligently recommending related follow-up questions to guide system exploration of guideline content.

Clinical decision support: providing evidence-based treatment recommendations and assisting doctors in real time to develop diagnosis and treatment plans.

Currently, the 'Cardiology Doctor Assistant' has comprehensively covered major cardiovascular diseases such as hypertension, coronary heart disease, heart failure, and atrial fibrillation, providing doctors with authoritative answers on diagnosis, treatment, and prevention based on the latest medical guidelines.

It is reported that the intelligent body was jointly developed by the Cardiology Department of Peking Jishuitan Hospital, iFlytek Technology (02158), and Tsinghua University. At the event, Professor Liu Wei from Peking Jishuitan Hospital, Dr. Yan Jun, CTO and Chief AI Scientist of iFlytek Technology, Dr. Zhu Xuguang, Assistant Dean of Tsinghua Advanced Intelligent Database Research Institute, Professor Zhang Yuhui from Fuwai Hospital of Chinese Academy of Medical Sciences, Professor Li Jing from Xuanwu Hospital of Capital Medical University, Professor Zu Lingyun from the Third Hospital of Peking University, and Professor Guo Caixia from Peking Union Medical College Hospital and other cardiovascular experts attended the intelligent body launch ceremony.

As a long-term explorer and practitioner in the field of AI medical, iFlytek Technology has independently developed a large-scale medical domain model, possessing a high-quality medical knowledge graph, rich experience in medical text corpus processing analysis and large-scale model application construction, responsible for the overall technical support and development of the cardiovascular guidelines interpretation intelligent body.

During the development of the intelligent body, Professor Liu Wei led a team of experts from Peking Jishuitan Hospital to define the functions and performance requirements of the intelligent body based on clinical practice needs, to ensure that it can meet clinical demands, provide feedback, help improve and optimize the model's performance. Meanwhile, Tsinghua University provided solid academic and talent support in the intelligent body project, conducting comprehensive evaluation and validation of the intelligent body model.

At the conference venue, Professor Liu Wei presented a detailed demonstration of the intelligent body's functions, introduced the usage methods and application scenarios of the intelligent body. During the Q&A session, the intelligent body's rapid response, accurate answers, and multi-modal interaction capabilities fully demonstrated the professionalism and practicality of the intelligent body.

Professor Liu Wei demonstrated the function of interpreting cardiovascular guidelines live at the conference.

The release of the Cardiovascular Guide Interpretation AI technology is another important exploration in empowering the medical field with AI technology. In the future, Jishuitan Hospital will serve as the application demonstration base for the Cardiovascular Guide Interpretation AI technology, further demonstrating and promoting the clinical application value of the AI technology. MedEase Technology will continue to collaborate with Peking Jishuitan Hospital and Tsinghua University to improve and optimize the Cardiovascular Guide Interpretation AI technology, including expanding disease coverage, enhancing personalized diagnosis and treatment decision-making capabilities, and promoting multidisciplinary collaboration in all aspects. This AI technology will also be available on MedEase Technology's medical AI platform to serve more doctors and patients.

Currently, AI models are considered as important application directions of large models, representing the optimal form for entering production scenarios. MedEase Technology will continue to innovate based on professional healthcare domain large models, delve into more specialized fields, enhance the quality and efficiency of medical services, and bring more convenience and benefits to doctors and patients.